
Phibro Animal Health Corporation PAHC
$ 22.45
-2.26%
Quarterly report 2024-Q4
added 02-05-2025
Country |
![]() |
IPO year |
2014 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Jack Bendheim |
Employees in the company |
1 700 |
Shares |
40.5 M |
Market Cap[1] |
$ 909 M |
EBITDA (LTM) |
$ 118 M |
P/E (LTM) |
45.43 |
P/S (LTM) |
0.83 |
EPS (LTM) |
0.49 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.